Skip to main content
. 2017 Feb 26;9(3):196. doi: 10.3390/nu9030196

Table 3.

Stool characteristics and adverse events recorded in pregnant women two weeks before the intervention and two, six, and 10 weeks after the intervention.

Weeks of Gestation 24 28 32 36
Weeks from the Start of Supplementation −2 2 6 10
Group P F P F P F P F
n 25 27 26 31 24 33 25 32
Stool frequency (times per day), median 0.9 1.0 0.8 1.0 * 1.1 1.0 1.2 1.0
Stool form score, mean 3.9 4.2 3.9 4.2 3.9 4.0 3.9 4.3
Frequency of abdominal pain (days per week), median 0 0 0 0 0 0 0 0
frequency of diarrhea (days per week), median 0 0 0 0 0 0 0 0

P = Placebo-group, F = Fructooligosaccharides-group. * P < 0.05 (Mann-Whitney U test).